1 01/04/2025 31/03/2026 2026-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-04-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 11280096 2025-04-01 2026-03-31 11280096 2026-03-31 11280096 2025-03-31 11280096 2024-04-01 2025-03-31 11280096 2025-03-31 11280096 2024-03-31 11280096 bus:RegisteredOffice 2025-04-01 2026-03-31 11280096 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 11280096 bus:Director1 2025-04-01 2026-03-31 11280096 core:WithinOneYear 2026-03-31 11280096 core:WithinOneYear 2025-03-31 11280096 core:AfterOneYear 2026-03-31 11280096 core:AfterOneYear 2025-03-31 11280096 bus:Director1 2025-03-31 11280096 bus:Director1 2026-03-31 11280096 bus:Director1 2024-03-31 11280096 bus:Director1 2025-03-31 11280096 bus:Director1 2024-04-01 2025-03-31 11280096 bus:Micro-entities 2025-04-01 2026-03-31 11280096 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 11280096 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 11280096 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 11280096 bus:FullAccounts 2025-04-01 2026-03-31
Company registration number: 11280096
Healthcure Pharma Limited
Unaudited filleted financial statements
31 March 2026
Healthcure Pharma Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Healthcure Pharma Limited
Directors and other information
Director Mr Jagdishkumar Ratilal Patel
Company number 11280096
Registered office 6th Floor, AMP House
Dingwall Road
Croydon
CR0 2LX
Accountants Doshi & Co. Accountants
6th Floor, AMP House
Dingwall Road
Croydon
CR0 2LX
Healthcure Pharma Limited
Report to the director on the preparation of the
unaudited statutory financial statements of Healthcure Pharma Limited
Year ended 31 March 2026
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31 March 2026 which comprise the statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Doshi & Co. Accountants
6th Floor, AMP House
Dingwall Road
Croydon
CR0 2LX
15 September 2026
Healthcure Pharma Limited
Statement of financial position
31 March 2026
2026 2025
£ £
Fixed assets 377 443
_______ _______
Current assets 20,499 17,575
Creditors: amounts falling due within one year ( 3,457) ( 669)
_______ _______
Net current assets 17,042 16,906
_______ _______
Total assets less current liabilities 17,419 17,349
Creditors: amounts falling due after more than one year ( 9,999) ( 12,204)
_______ _______
Net assets 7,420 5,145
_______ _______
Capital and reserves 7,420 5,145
_______ _______
Notes to the financial statements
Healthcure Pharma Limited
Year ended 31 March 2026
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
2. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2026
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Mr Jagdishkumar Ratilal Patel ( 290) 14,500 ( 17,027) ( 2,817)
_______ _______ _______ _______
2025
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Mr Jagdishkumar Ratilal Patel ( 1,284) 994 - ( 290)
_______ _______ _______ _______
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 15 September 2026 , and are signed on behalf of the board by:
Mr Jagdishkumar Ratilal Patel
Director
Company registration number: 11280096
The company is a private company limited by shares, registered in England and Wales.